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Abstract
Background: An outbreak of aseptic meningitis occurred in Tianshui city of Gansu Province, the People’s Republic
of China, from March to June 2005. A total of 85 patients were clinical confirmed as aseptic meningitis in this
outbreak.
Results: CVA9 was mainly responsible for this outbreak supported by the clinical manifestations of the patients,
epidemiological data of the outbreak, the results of RT-PCR and complete VP1 sequence determination,
conventional neutralization assays, IgM serological assays, viral isolation and phylogenetics analysis. Through
phylogenetic analysis and homogeneity analysis for partial VP1 gene, the nucleotide and amino acid homologies
between Gansu isolates and former Chinese CVA9 strains were 88.2%-96.1% and 97.2%-99.2%, respectively. Multiple
transmission chains of CVA9 occurred in different provinces or years in China. Moreover, in order to clarify the
genotype of CVA9, Gansu CVA9 strains isolated in this outbreak were compared with other CVA9 isolates based on
VP1/2A junction regions (genotyping region) and they might belong to a new genotype of CVA9, which could be
assigned for genotype XIII,
Conclusions: CVA9 was confirmed as the pathogen responsible for this outbreak. The phylogenetic analysis
indicated that the CVA9 strains isolated in this outbreak might belong to a new genotype.
Background
Human Enteroviruses (HEV) comprise more than 80
distinct serotypes within the Picornaviridae family, and
are currently classified into five species: Poliovirus and
HEV-A, HEV-B, HEV-C, and HEV-D [1]. Most infec-
tions are asymptomatic, but enteroviruses can cause a
wide variety of clinical diseases, the most common of
the potentially severe enterovirus disease in pediatric
patients remains aseptic meningitis. Serotypes of the
HEV-B species including CVB1-6, ECHO, CVA9,
HEV69 and HEV73 are the most frequently implicated
[2-6], which could cause sporadic cases, outbreaks or
epidemics of aseptic meningitis worldwide including
China [6].
In China, the repeated outbreaks of HEV-associated
diseases occurred in recent years, and these patients
were reported to have an aseptic meningitis symptom
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an outbreak of aseptic meningitis in Tianshui city of
Gansu province, China, from March to June 2005. The
etiological agent responsible for this outbreak was iden-
tified and the genetic characterizations of virus strains
that were isolated from this outbreak were also analyzed.
Methods
The collections of clinical specimens in this outbreak
In this outbreak, the clinical specimens were collected
from 22 out of 85 patients during Apirl to June. Like
other 63 cases, these 22 patients came from Maiji dis-
trict of Tianshui city were hospitalized cases and con-
firmed as aseptic meningitis when these patients were
admitted to the hospital. So it clearly showed the epide-
miological linkage between 22 patients and 63 other
patients.
10 cerebrospinal fluids (CSF), 22 stool samples and 22
serum samples were collected from 22 patients with
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infection after onset; 3 patients were also found to have
convalescent sera. A total of 32 etiology specimens and
25 sera obtained during this outbreak were stored at
-80°C and -20°C, respectively, for further analysis.
Viral RNA extraction, direct reverse transcription-
polymerase chain reaction and sequences determination
Viral RNA was directly extracted from the clinical speci-
mens using a QIAamp Mini Vial RNA Extraction Kit
(Qiagen, Valencia, CA, USA). 10 CSF specimens and 22
stool samples from 22 patients was performed with
direct reverse transcription-polymerase chain reaction
(RT-PCR) by the pan-enterovirus primer pair including
primer PE1 and PE2 as previously described [9].
Virus Isolation and identification
10 CSF specimens and 22 stool samples were separately
inoculated into human rhabdomyosarcoma (RD) cell
lines and were cultured in a maintenance medium at
36°C. Cultures that exhibited a characteristic enterovius
cytopathic effect (CPE) were identified by RT-PCR and
sequencing with the following method. If no CPE was
observed in the cultures, these were further cultured for
another 7 days. Viral RNA was extracted from culture
with CPE by using the QIAamp mini viral RNA extrac-
tion kit (Qiagen, Valencia, CA, USA). The entire VP1
gene was amplified by RT-PCR with the primer pairs
including the previous reported primer pair 008 and 011
[2]. The amplification products were purified using a
QIAquick Gel Extraction Kit (Qiagen), and the ampli-
cons were bidirectionally sequenced using an ABI
PRISM 3100 Genetic Analyzer (Applied Biosystems,
Hitachi, Japan).
Identification of the genotype of CVA9
Though entire VP1 region were obtained for serotyping
of human enterovirus, few sequences were available at
GenBank, so it is difficult to analyze the genetical link-
age of sequences between China and other countries. In
order to clarify the genotype of CVA9, the genotyping
region (VP1/2A region) was also amplified with the pre-
vious reported primer pair named primer VP+ and 2A-
[10]. The RT-PCR products were purified and
sequenced with the above mentioned method.
Sequence Analysis
The sequence data were aligned, edited, and assembled
to obtain the entire VP1 gene and VP1/2A region using
Sequencher version 4.0.5 (GeneCode, Ann Arbor, MI,
USA). Sequence alignments were created with ClustalX
software 1.81, the pairwise sequence identities of the
nucleotide and deduced amino acid sequences were cal-
culated with BioEdit software 7.0. The genetic distances
were analyzed with Kimura 2-parameter method of
MEGA 4.0 program, and neighbor-joining of phyloge-
netic analysis were used to provide a more reliable infer-
ence of phylogeny with MEGA 4.0 program.
Serology detection of Coxsackievirus IgM antibody
22 acute-phase sera collected from the clinical con-
firmed cases within 2-29 days after onset were detected
Coxsackievirus immunoglobulin M (IgM) antibodies
using an Serion ELISA classic Coxsackievirus IgM test
kits (Institute Virion/Serion GmbH, Wurzburg, Ger-
many). This kit is quantitative and qualitative tests for
detection of human antibodies in serum or plasma
against all serotypes of Coxsackievirus.
Neutralization Test
In this study, according to the methods previously
described [11], conventional neutralization test was also
performed with three pairs of paired serum samples,
and the entire virion of strain Gansu05-1/GS/CHN/2005
isolated in this outbreak and identified was used as the
neutralization virus and the 50% cell infectious dose
(CCID50/50 μl) was calculated according to the Kärber
formula [12].
Nucleotide sequence accession numbers
The nucleotide sequence of the complete VP1 gene and
VP1/2A region for representative strain Gansu05-1/GS/
CHN/2005, which was determined in this study, has
been deposited in the GenBank nucleotide sequence
database under accession number GQ294574 and
GQ294575, respectively.
GenBank accession numbers for each human entero-
virus were shown as follows: CVA9(D00627), CVA12
(AF081302), CVA16(U05876), CVA19(AF081308), CVA24
(AF081311), CVB1(M16560), CVB2(AF081312), CVB3
(M16572), CVB4(D00149), CVB5(X67706), CVB6
(AF081313), E1(AF081314), E2(AF081315), E3(AF081316),
E4(AF081317), E5(AF081320), E6 (AF081321), E7
(AF081324), E9(X92886), E11(X80059), E12(X79047), E13
(AF081327), E14(AF081328), E15(AF081329), E16
(X89545), E17(AF081330), E18(AF081331), E19
(AF081332), E20(AF081333), E21(AF081334), E24
(AF081335), E25(AF081336), E26(AF081337), E27
(AF081338), E29(AF081339), E30(AF081340), E31
(AF081344), E32(AF081345), E33(AF081346), EV68
(AF081348). GenBank accession numbers for each CVA9
were shown as follows: Griggs(D00627), 06.109.3344
(FJ868282), FJ00-127(AY573578), FJ98-90(AY573577),
78-97(AB268124), 49-98(AB268123), 148-00(AB268121),
03-171FCR2(AB167980), 03-144NPC3(AB167979),
03-132NPR2(AB167978), YZ047/SD/CHN/2005/CA9
(GQ246517), 04318/SD/CHN/2004/CA9(GQ329731),
01332/SD/CHN/2001/CA9(GQ329730), 00365/SD/CHN/
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Page 2 of 92000/CA9(GQ329729), 97186/SD/CHN/1997/CA9
(GQ329728), 97089/SD/CHN/1997/CA9(GQ329727),
TR081056-05(AM236967), Can-1-85 (AF166250), Fin-2-
95(AF166251), Net-1-79(AF166252), Net-1-64(AF166253),
Net-1-81(AF166249), Fin-1-88(AF166248), Den-1-71
(AF166247), Net-1-59(AF166246), Net-1-63(AF166245),
Net-1-67(AF166244), Net-1-61(AF166243), Mex-1-75
(AF166242), Hon-1-77(AF166241), US-CO-1-74
(AF166240), US-MD-1-88(AF166239), Can-1-86
(AF166238), US-NC-1-83(AF166237), Net-1-71
(AF166236), Net-1-78(AF166235), Thai-1-93(AF166234),
Net-1-73(AF166233), US-MS-1-78(AF166232), Net-2-79
(AF166231), Fin-2-83(AF166230), Fin-1-83(AF166229),
Fin-2-97(AF166228), Fin-1-97(AF166227), Fin-1-96
(AF166226), Fin-2-96(AF166225), Fin-3-96(AF166224),
Fin-2-94(AF166223), Fin-1-94(AF166222), Fin-1-95
(AF166221), Fin-2-93(AF166220), Fin-1-93(AF166219).
Results
Epidemiological investigation of this outbreak
On 4 March 2005, a child was clinical diagnosis as asep-
tic meningitis in Tianshui city of Gansu Province. Sub-
sequently, the number of cases with clinical confirmed
aseptic meningitis increased rapidly. Up to 29 June
2005, a total of 85 cases, which concentrated in Maiji
district of Tianshui city of Gansu province, were clinical
confirmed as aseptic meningitis by Tianshui City Peo-
ple’s Hospital in this outbreak (Figure 1). Also through
the epidemiological investigation, no similar case was
reported in other districts of Tianshui city.
The clinical symptoms of the patients were fever
(>37.5°C) (79/79, 6 cases missing), headache (67/85) and
vomiting (56/85). The incidence of the relevant cases
peaked in late May to early June. All patients were less
than 13 years old, and a majority of these patients were
4 - 5y e a r so l d .N u m b e r so fG r e g a r i o u sc h i l d r e n ’s cases
(from kindergarten and primary school) were more than
those of scattered children. All patients had good prog-
nosis, and no fatal case was found in this outbreak.
Laboratory confirmation of CVA9 as the pathogenic
agent in this outbreak
The specimens collected from 22 patients were identi-
fied by pan-entero RT-PCR, virus isolation/molecular
t y p i n g ,I g ME L I S Aa n dN T ,a n dt h er e s u l t sw e r e
showed in the table 1.
4 CSF sample and 12 stool samples (including 3 CSF
samples and 3 stool samples detected from 3 patients)
were successfully amplified with pan-enteroviruse pri-
mer pair. It indicated the enteroviruse infection respon-
sible for this outbreak.
Among them, 8 samples including 2 CSF and 6 stool
samples were positive for virus isolation/VP1 RT-PCR,
and the other 8 samples were negative and only positive
for pan-enteroviruse directly RT-PCR, this maybe due to
the lower titer of the virus in the clinical samples. As for
the viral isolation, 2 CSF and 6 stool samples out of 32
samples (including one CSF and one stool sample from
one patient) were observed with the characteristic enter-
ovirus CPE, which appeared within two passages after
Figure 1 Distribution of aseptic meningitis cases in Tianshui city of Gansu Province by date. On March 4, 2005, the first case appeared.
The number of similar cases had increased dramatically. By June 29, 2005, the outbreak had affected 85 children. The numbers above column
indicated 22 out of 85 patients in this outbreak.
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fied to obtain the predicted products of 906 bp.
Sequence determination revealed that eight viral iso-
lates exhibited 99.9% to 100% homology in their nucleic
acid sequences. Therefore, the data showed that all the
patients were infected with the similar virus. A viral iso-
late designated as strain Gansu05-1/GS/CHN/2005 was
used for phylogenetic analysis. Furthermore, phyloge-
netic tree was conducted on the basis of the entire VP1
sequences of human enterovirus prototype strains indi-
cated that the sequences was very close to the prototype
strain of CVA9 (strain Griggs) (Figure 2).
In ELISA detection for Coxsackievirus IgM, 10 sera
obtained positive results with the proportion of positive
samples being 45.5%. This result also supported that
Coxsackievirus infections occurred in this outbreak.
Conventional neutralization test results revealed that
the neutralization titers of the convalescent-phase sam-
ples were at least four times higher than those of the
acute-phase samples for all three pairs. This finding also
suggested that CVA9 was associated with this outbreak.
Phylogenetic analysis of CVA9
Only the partial VP1 gene (nt2583-nt3338, relative to
strain Griggs) of former Chinese CVA9 strains was
available in the GenBank database. Thus, in order to
determine the molecular epidemiology of CVA9 in
China, the phylogenetic dendrogram (Figure 3) was con-
ducted with 12 Chinese CVA9 strains, 5 strains from
other countries and the prototype strain based on this
region. 12 Chinese CVA9 strains (including strain FJ98-
90 and FJ00-127 from Fujian province, strain YN148-00,
YN49-98 and YN78-97 from Yunnan province, strain
01332/SD/CHN/2001/CA9, 97089/SD/CHN/1997/CA9,
97186/SD/CHN/1997/CA9, YZ047/SD/CHN/2005/CA9,
04318/SD/CHN/2004/CA9 and 00365/SD/CHN/2000/
CA9 from Shandong province) were isolated during
1997 to 2005; 5 strains from other countries composed
of 3 Japanese strains (stain 03-171FCR2, 03-144NPC3
and 03-132NPR2) isolated in 2003, one strain (strain
06.109.3344) isolated in Australia in 2006 and one strain
(strain TR081056-02) isolated in France in 2005. Except
the prototype strain, 17 CVA9 strains could be divided
into 4 different lineages (lineage 1-4). 10 strains includ-
ing 8 Chinese strains (YN148-00, YN49-98, FJ98-90,
FJ00-127, 01332/SD/CHN/2001/CA9 and 97089/SD/
CHN/1997/CA9), one Japanese strain (strain 03-
132NPR2) and one Australian strain (strain 06.109.3344)
belong to lineage 1; 7 strains including 5 Chinese strain
(Gansu05-1/GS/CHN/2005, 97186/SD/CHN/1997/CA9,
YZ047/SD/CHN/2005/CA9, 04318/SD/CHN/2004/CA9
and 00365/SD/CHN/2000/CA9) and two Japanese
Table 1 Laboratory confirmation of the pathogenic agent in this outbreak*
Cases Molecular detection Serology detection
Direct RT-PCR for
pan-enterovirus
Virus isolation/
serotyping
ELISA testing for Coxsackievirus
IgM of 22 acute-phase sera
Neutralization Test
CSF Stool CSF Stool Neutralization titer
in acute-phase
Neutralization titer
in convalescent
1 + + +/CVA9 +/CVA9 + <1:20 1:501
2 + + - - + <1:20 1:1000
3 + + - +/CVA9 + <1:20 >1:1024
4 + / +/CVA9 / - / /
5 - + - +/CVA9 + / /
6 - + - +/CVA9 + / /
7 - + - +/CVA9 + / /
8 - + - +/CVA9 + / /
9- + -- + / /
10 - + - - - / /
11 / + / - - / /
12 / + / - - / /
13 / + / - - / /
14 / - / - + / /
15 / - / - + / /
Total 4 12 2//CVA9 6//CVA9 10 At least four times higher for all three pairs of paired
serum samples
* this table only showed the positive results of 22 cases in this outbreak;
/ showed no specimens obtained in this outbreak.
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Page 4 of 9Figure 2 Dendrogram illustrating sequence relationships among the studied CVA9 isolates and the prototype strains of Human
enterovirus. The phylogenetic tree constructed based on analysis of VP1 gene was drawn by bootstrap analysis (500 times) using the
Neighbor-joining of MEGA 4.0 software. The triangle in the figure showed strain Gansu05-1/GS/CHN/2005 was sequenced in this study.
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Page 5 of 9strains (strain 03-171FCR2 and 03-144NPC3) belong to
lineage 2; strain YN 78-97 from China form lineage 3;
and strain TR081056-02 from France form lineage 4.
The genetic distances between and within lineages
were 0.11-0.21 and 0.04-0.07, respectively. Chinese
CVA9 strains were concentrated in lineage 1, 2, and 3.
The result of the phylogenetic tree indicated that multi-
ple transmission chains occurred in different provinces
or years. The nucleotide and amino acid homologies
between strain Gansu05-1/GS/CHN/2005 and other
Chinese CVA9 strains within this partial VP1 gene were
88.2%-96.1% and 97.2%-99.2%, respectively. And strain
Gansu05-1/GS/CHN/2005 isolated in this outbreak was
the closest to strain 97186/SD/CHN/1997/CA9 isolated
in Shandong province in 1997.
Due to few VP1 sequences were available at GenBank,
in order to investigate the genetic relationships between
strain Gansu05-1/GS/CHN/2005 and other CVA9, phy-
logenetic analysis were conducted on the basis of the
sequences in the junction region between the VP1 cap-
sid protein and the 2A protease genes (VP1/2A, nt3258-
nt3407, relative to strain Griggs) with 37 CVA9 strains
(Figure 4). CVA9 genotypes have been reported to
define as clusters of related strains with <15% nucleotide
divergence in this region [10], and CVA9 strains could
be assigned to 12 genotypes, which were designated gen-
otype I-XII in the chronological order of the isolation of
the earliest virus strain in each genotype [10]. In this
study, the 24.0% nucleotide divergence was found
between strain Gansu05-1/GS/CHN/2005 and the
prototype strain Griggs; compared with the genotype I-
XII of CVA9 strains, the nucleotide divergence of strain
Gansu05-1/GS/CHN/2005 were 17.3%-32.6%. Moreover,
strain Gansu05-1/GS/CHN/2005 formed an independent
branch in the phylogenetic tree compared with other
genotypes of CVA9 (Figure 4). So, both the results of
phylogenetic analysis and nucleotide divergence indi-
cated that strain Gansu05-1/GS/CHN/2005 might be a
new genotype of CVA9, and could be assigned the geno-
type XIII. The genetic distances between 13 genotypes
were 0.17-0.41, higher than those within genotypes, and
the genetic distances between genotype XIII and other
12 genotypes were also 0.21-0.40. Unfortunately, due to
few sequences of VP1/2A region available in GenBank
database, other Chinese CVA9 strains were unable to
analyze for genotyping.
In this study, the RGD motif within the C-terminal
extension of the VP1 capsid protein of CAV9 [13] was
also found to be fully conserved among 13 CAV9 geno-
types including strain Gansu05-1/GS/CHN/2005 which
suggests that the motif, although not essential for virus
viability in cell culture conditions, plays a vital role in
replication of the virus in humans.
Discussion
Enteroviruses represent the main etiological agents of
epidemics of viral meningitis and especially the sero-
types related to the HEV-B species, and more than 50%
of meningitis cases were due to echovirus 30 [14]. In
2005, outbreak of aseptic meningitis occurred in
Figure 3 Dendrogram illustrating sequence relationships among the studied CVA9 isolates and the prototype Griggs strain based on
VP1 gene. The triangle in the figure showed strain Gansu05-1/GS/CHN/2005 was sequenced in this study. The circle in the figure showed CVA9
strains isolated in China.
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Page 6 of 9Tianshui city of Gansu Province, China. The results of
the present study indicated that CVA9 was mainly
responsible for this outbreak. This postulation is sup-
ported by the clinical manifestations of the affected
patients, epidemiological data of the outbreak, the
results of RT-PCR and sequence determination, conven-
tional neutralization assays, IgM serological assays, viral
isolation and phylogenetics analysis.
CVA9 is a member of the A subgroup which exhibits
the typical pathogenicity in newborn mice [15], while
the disease pattern in humans is more closely related to
CVB infections. CVA9 is also one of the enteroviruses
which may be associated with aseptic meningitis, and
clinical CVA9 infections are common [16,17].
The genetic heterogeneity of enteroviruses makes it
difficult to develop molecular typing that is both reliable
and easy to perform. The genomic sequence encoding
the VP1 capsid protein gives excellent results because of
the high correlation between serotype and genetic infor-
mation, and the availability of a complete database of
reference strains isolated in the 1950’s and 1960’s. In
this study, the pathogen was identified as CVA9 based
Figure 4 Dendrogram illustrating sequence relationships among the studied CVA9 isolates and the prototype Griggs strain based on
VP1/2A junction region. The triangle in the figure showed strain Gansu05-1/GS/CHN/2005 was sequenced in this study.
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sis and homogeneity analysis for partial VP1 gene, the
strain Gansu05-1/GS/CHN/2005 shared highly homol-
ogy with strains 97186/SD/CHN/1997/CA9 from Shan-
dong province, belonging to different lineages with
other 11 Chinese CVA9 strains. It indicated that there
were multiple transmissions chains of CVA9 circulation
in different provinces in China, and the similar virus
were also found in Japan.
However, it is difficult for systematic genotyping based
on VP1 gene because few complete CVA9 VP1
sequences available in the world. Santti et al. divided
CVA9 strains into 12 genotypes using the criteria desig-
nated for PVs that strains sharing >85% identity in the
VP1/2A junction region belong to the same genotype
[18]. By compared this region of the CVA9 genome, it
was found that strain Gansu05-1/GS/CHN/2005 isolated
in this outbreak might be a new genotype of related
sequences based on this criteria and could be assigned
for genotype XIII. It seemed that this genotype virus cir-
culated in China in recent years. So far, a number of
genetically distinct genotype of viruses may currently
circulate in the world. The identification of a new CVA9
genotype in China was useful for identifying the source,
tracking transmission pathways and documenting
changes in the viruses present in particular regions over
time. However, due to no other Chinese CVA9
sequences of VP1/2A was available to analyze for geno-
t y p i n g ,i ti sv e r yd i f f i c u l tt ok n o wt h et i m eo ft h i sn e w
genotype occurred, and whether co-circulated of other
CVA9 genotypes existed.
In recent years, CVA9 was also isolated in many other
countries including Spain, Finland, Canada, Netherland
and United States etc through routine diagnosis for clin-
ical samples from patients suspected viral central ner-
vous system infection [10,19]. In all genotypes of CVA9,
most of the strains within each genotype showed geo-
graphical clustering; evidence of long-distance importa-
tion of virus strains was also reported [10]. However,
because of the limit data of Chinese CVA9 strains avail-
able, it was very difficult to clarify the molecular epide-
miology of CVA9 in China.
In conclusion, this is the first reporting the outbreak
of aseptic meningitis caused by CVA9 in China, and a
new genotype of CVA9 was found based on the
sequences of VP1/2A region. However, further analysis
is needed to investigate the evolution of the CVA9 by
obtained more sequences of virus strains and to find out
their genetic relationships, and molecular epidemiologi-
cal surveillance of CVA9 should also be strengthened.
Conclusion
An outbreak of aseptic meningitis occurred in Tianshui
city of Gansu Province, the People’s Republic of China
in 2005. In this study, CVA9 was confirmed as the
pathogen responsible for this outbreak. The phyloge-
netic analysis indicated that the CVA9 strains isolated in
this outbreak might belong to a new genotype.
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